AVINGER

avinger-logo

Avinger, Inc., a medical device company, engages in developing catheter-based technologies for treating vascular diseases. It offers Wildcat, a catheter that helps physicians in treating peripheral artery disease. The company also produces the Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. The company was founded in 2007 by John B. Simpson and is based in Redwood City, California.

#SimilarOrganizations #People #Financial #Website #More

AVINGER

Social Links:

Industry:
Health Care Manufacturing Medical Medical Device

Founded:
2007-01-01

Address:
Redwood City, California, United States

Country:
United States

Website Url:
http://www.avinger.com

Total Employee:
101+

Status:
Active

Contact:
650-363-2400

Email Addresses:
[email protected]

Total Funding:
226.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network


Similar Organizations

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

pulse-biosciences-logo

Pulse Biosciences

Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.

scitech-medical-logo

Scitech Medical

Scitech is a manufacturer of medical devices committed to developing technology to treat cardiac and vascular diseases.

soundbite-medical-solutions-logo

Soundbite Medical Solutions

Soundbite is a medical device company developing products in the field of vessel preparation for management and treatment.


Current Advisors List

don-a-lucas_image

Don A. Lucas Board Member @ Avinger
Board_member
2013-01-01

not_available_image

James Muzzy Board of Directors @ Avinger
Board_member

not_available_image

Kenneth M. Novack Chairman of the Board @ Avinger
Board_member

not_available_image

John Delfino Board of Directors @ Avinger
Board_member

james-mcelwee_image

James McElwee Board of Directors @ Avinger
Board_member
2011-01-01

Current Employees Featured

himanshu-patel_image

Himanshu Patel
Himanshu Patel Chief Technology Officer @ Avinger
Chief Technology Officer

c-todd-ransick_image

C. Todd Ransick
C. Todd Ransick VP - Brand, Interactive & Creative @ Avinger
VP - Brand, Interactive & Creative
2013-01-01

mark-weinswig_image

Mark Weinswig
Mark Weinswig Chief Financial Officer @ Avinger
Chief Financial Officer

not_available_image

Ted Karmon
Ted Karmon VP, Sales @ Avinger
VP, Sales

jaafer-golzar_image

Jaafer Golzar
Jaafer Golzar Chief Medical Officer @ Avinger
Chief Medical Officer
2018-07-01

jeffrey-m-soinski_image

Jeffrey M. Soinski
Jeffrey M. Soinski President & CEO @ Avinger
President & CEO
2014-12-01

not_available_image

Phil Preuss
Phil Preuss Chief Marketing Officer @ Avinger
Chief Marketing Officer
2020-01-01

Founder


jd-simpson_image

JD Simpson

Stock Details


Company's stock symbol is NASDAQ:AVGR

Investors List

the-capital-royalty-fund_image

CRG

CRG investment in Post-IPO Equity - Avinger

lucas-venture-group_image

Lucas Venture Group

Lucas Venture Group investment in Series E - Avinger

lucas-venture-group_image

Lucas Venture Group

Lucas Venture Group investment in Debt Financing - Avinger

lucas-venture-group_image

Lucas Venture Group

Lucas Venture Group investment in Series C - Avinger

Official Site Inspections

http://www.avinger.com Semrush global rank: 2.74 M Semrush visits lastest month: 5.94 K

  • Host name: 244.110.148.146.bc.googleusercontent.com
  • IP address: 146.148.110.244
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Avinger" on Search Engine

Home | Avinger

Next-Gen OCT-Guided CTO Crossing System Now FDA Cleared. Learn more about onboard image-guidance for safety and precisionSee details»

Avinger Announces Strategic Partnership and up to $15 Million โ€ฆ

Mar 7, 2024 REDWOOD CITY, CA / ACCESSWIRE / March 6, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and โ€ฆSee details»

Avinger Company Profile - Craft

2024-04-09. Revenue. $7.7 M. FY, 2023. Company Summary. Overview. Avinger is a medical device company that designs, manufactures, and sells image-guided and โ€ฆSee details»

Avinger - Crunchbase Company Profile & Funding

Avinger, Inc., a medical device company, engages in developing catheter-based technologies for treating vascular diseases. It offers Wildcat, a catheter that helps โ€ฆSee details»

Avinger, Inc. (AVGR) Company Profile & Facts - Yahoo Finance

Description. Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by โ€ฆSee details»

Avinger Announces Strategic Partnership and up to $15 Million โ€ฆ

07-Mar-2024. Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge. Initial $7.5 Million Strategic Investment. โ€ฆSee details»

Investor Relations | Avinger

Vascular disease isnโ€™t going away. Real people continue to fight the progression and complications that result from PAD. Weโ€™ve won many battles but the war goes on and we donโ€™t take our responsibility to create โ€ฆSee details»

Investor Relations | Avinger

Jul 27, 2023 H.C. Wainwright 23rd Annual Global Investment Conference (Virtual) Avinger will host a group presentation and one-on-one investor meetings with โ€ฆSee details»

Healthcare Professionals | Avinger

Events with Avinger. Visit Avinger at the following upcoming events to learn more on how Lumivascular is radically changing the way vascular disease is treated. Past events. Case Studies. Patient Stories. Clinical โ€ฆSee details»

2024-03-06 | NDAQ:AVGR | Press Release | Avinger Inc

Mar 6, 2024 News Press Releases. Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge. AVGR | March 6, 2024. โ€ฆSee details»

Avinger - Contacts, Employees, Board Members, Advisors & Alumni

Avinger is a medical device company engaged in developing catheter-based technologies and devices for treating vascular diseases.See details»

Earnings call: Avinger announces Q4 and FY 2023 results with โ€ฆ

Mar 21, 2024 Avinger (NASDAQ: AVGR ), a medical device company specializing in innovative treatments for vascular diseases, reported its financial outcomes for the fourth โ€ฆSee details»

Earnings call: Avinger announces Q4 and FY 2023 results with โ€ฆ

Mar 21, 2024 Avinger (NASDAQ: AVGR ), a medical device company specializing in innovative treatments for vascular diseases, reported its financial outcomes for the fourth โ€ฆSee details»

Avinger - Funding, Financials, Valuation & Investors - Crunchbase

Avinger has raised a total of. $316.1M. in funding over 16 rounds. Their latest funding was raised on Mar 6, 2024 from a Post-IPO Equity round. Avinger is registered under the โ€ฆSee details»

Avinger Announces Strategic Partnership and up to $15

Mar 7, 2024 Accesswire. Avinger Announces Strategic Partnership and up to $15 Million Equity Funding Agreement with Zylox-Tonbridge. Provided by Accesswire. Mar 6, 2024 โ€ฆSee details»

Avinger, Inc. (AVGR) CEO Jeff Soinski on Q1 2021 Results

We've added a new role in the organization in 2021, which is a sales associate role, which will work -- who will work with an established territory sales manager to help to develop a โ€ฆSee details»

AVGR Press Release: Avinger Announces Strategic Partnership โ€ฆ

Mar 6, 2024 The strategic partnership provides up to $15 million of equity funding from Zylox-Tonbridge in two tranches, a licensing agreement providing access for Avinger's โ€ฆSee details»

Avinger, Inc. (NASDAQ:AVGR) Q4 2023 Earnings Call Transcript

Mar 21, 2024 Avinger, Inc. (NASDAQ: AVGR) Q4 2023 Earnings Call Transcript March 20, 2024. Avinger, Inc. misses on earnings expectations. Reported EPS is $-3.93 EPS, โ€ฆSee details»

Avinger Announces Strategic Partnership and up to $15

Mar 6, 2024 REDWOOD CITY, CA / ACCESSWIRE / March 6, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company developing and โ€ฆSee details»

Policies | Avinger

We receive and store any information you enter on Avinger or provide to us in any other way. The types of Personal Information collected includes all information you may enter โ€ฆSee details»